Background and objectives: Acute kidney injury is an independent predictor of short-and long-term survival; however, data on the relationship between reversible transitory decline of kidney function and chronic kidney disease (CKD) are lacking. We assessed the prognostic value of temporary renal function decline on the development of long-term CKD.
at day 3 after surgery were excluded for the analyses that examined the primary end point (n ϭ 234). Of the remaining 2218 patients, 1308 (59%) had a Scr measurement at least 1 year after surgery. These 1308 patients composed the final analyzed study population. Baseline characteristics between the source population and the final study population were compared to rule out the possibility of selection bias. No significant differences with respect to all baseline characteristics, cardiac risk factors, and medication use at discharge between the two populations were observed. The study complies with the Declaration of Helsinki, and enrollment was performed after approval of the hospital's ethics committee and after informed consent from all patients (or their guardians).
Renal Function Assessment
Scr was assessed by means of a nonkinetic alkaline picrate (Jaffé) method (11) . eGFR was calculated by using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula: eGFR ϭ 141 ϫ min (Scr/ (12) . Scr is micromoles per liter, is 0.7 for women and 0.9 for men, a is Ϫ0.329 for women and Ϫ0.411 for men, min indicates the minimum of Scr/ or 1, and max indicates the maximum of Scr/ or 1.
Renal Function Groups
Before surgery (1 to 3 days), Scr level was measured at baseline in all patients. Scr level was measured at day 1 or 2 and day 3 after surgery. Patients were categorized into three groups on the basis of changes in CKD-EPI eGFR from baseline to day 1 or 2 and from day 1 or 2 to day 3: Group 1, unchanged or improved renal function (change in CKD-EPI GFR function Ϫ10 to 10% compared with baseline); group 2, temporary decline of renal function (temporary decline Ͼ10% at day 1 or 2, then complete recovery within 10% of baseline value at day 3); and group 3, persistent decline of renal function (Ͼ10% decrease compared with baseline). Baseline CKD-EPI eGFR was defined as the value recorded within 3 days before surgery. The purpose of this study was to investigate the prognostic value for the risk for development of CKD after small decrements in renal function. On the basis of our previous studies, we used a cutoff value of Ϯ10% in eGFR (8, 10) . To confirm the validity of our initial definition, we performed additional sensitivity analyses by repeating all analyses using the Risk, Injury, Failure, Loss, and ESRD (RIFLE) classification for AKI (13) .
Follow-up and End Points
During the follow-up period, long-term Scr level was used to determine the primary end point of the development of incident CKD. Long-term creatinine measurements had to be obtained at least 1 year after surgery. The median follow-up period between date of surgery and last Scr level recorded was 5.0 years (interquartile range [IQR] 2.6 to 8.5). The primary outcome of interest, incident CKD, was defined using the National Kidney Foundation Disease Outcome Quality Initiative (NKF/DOQI) definition of eGFR Ͻ60 ml/min per 1.73 m 2 , calculated using the CKD-EPI equation (11) . In addition, for prevention of the occurrence of information bias as a result of misclassification of CKD, patients were classified as having CKD only when the CKD-EPI eGFR was decreased by at least 25% from the baseline GFR. In 916 (70%) patients, more than one Scr measurement was used to define the presence of CKD.
Statistical Analysis
Continuous data were described as mean Ϯ SD or median (IQR). Categorical data were presented as percentage frequencies and compared using 2 
Results

Description of the Study Population
The study population consisted of 1308 consecutive patients who had peripheral arterial disease and were referred for elective major vascular surgery. Lower extremity revascularization was performed in 527 (40%) patients, abdominal aortic surgery in 514 (39%) patients, and carotid surgery in 267 (21%) patients. In the source population (n ϭ 2452), 1569 (64%) patients were classified as having normal or improved renal function, whereas 441 (18%) and 436 (18%) had temporary and persistent declines in renal function, respectively. Of the patients in the final study population, 815 (62%) had no change or had improvement in CKD-EPI eGFR compared with baseline during the first 3 postoperative days. Temporary and persistent declines of renal function were observed in 261 (20%) and 232 (18%) patients, respectively. At baseline, patients with temporary renal function decline had a significantly lower CKD-EPI eGFR compared with patients with normal renal function (P ϭ 0.01). Mean changes in CKD-EPI eGFR on day 1 or 2 and day 3 for the groups are shown in Figure 1 . Patients with temporary or persistent renal function decline more often had vascular disease, resulting in a higher incidence of polyvascular disease (P ϭ 0.03; Table 1 ). Risk factors for CKD, including hypertension and chronic heart failure, were more often present in patients with temporary or persistent renal function decline (P ϭ 0.05). There was a significant trend for increased use of statins, diuretics, and angiotensin-converting enzyme inhib-itors in patients with temporary or persistent renal function decline (P Ͻ 0.05). oped CKD. In contrast, 94 (32%) and 84 (36%) patients with temporary and persistent renal function declines, respectively, developed CKD. There was a significant association between the presence of perioperative renal function decline and the development of CKD in unadjusted analyses (P Ͻ 0.001). In multivariate regression analyses, adjusted for demographics, cerebrovascular history, cardiovascular risk factors, BP-lowering agents, and time of Scr measurement, the presence of temporary renal function decline was independently associated with an increased risk for CKD (RR 3.4; 95% CI 2.7 to 4.1) compared with no change or improvement in renal function. Persistent renal function decline in the perioperative period was associated with a 3.6-fold increased risk for CKD (RR 3.6; 95% CI 2.8 to 4.4). Other covariates that were significantly associated with the outcome of interest were age (RR 1.04; 95% CI 1.02 to 1.06), diabetes (RR 1.9; 95% CI 1.4 to 2.5), and smoking (RR 1.2; 95% CI 1.0 to 1.4).
Long-Term Incident CKD
Sensitivity Analysis
To evaluate the strength of the 10% cutoff value for temporary changes in CKD-EPI eGFR, we performed additional analyses using 20, 30, 40, and 50% cutoff values, respectively ( Table 2) . Using a 20% change in CKD-EPI eGFR compared with baseline, temporary renal function decline was independently associated with a 3.5-fold increased risk (RR 3.5; 95% CI 2.8 to 4.2). Furthermore, for a 50% change in CKD-EPI eGFR compared with baseline, a comparable independent association was observed (RR 3.8; 95% CI 2.9 to 4.3). Importantly, as the change in CKD-EPI eGFR cutoff values increased, the independent risk remained stable for patients with a temporary decline of renal function. In contrast, performing the same analyses for patients with a persistent decline of perioperative renal function, there was a graded relation between the cutoff value and the estimated risk for CKD up to a cutoff value of 30%. Using a 30% change in CKD-EPI eGFR, there was a 4.3-fold increased risk (RR 4.3; 95% CI 3.3 to 5.4); however, when a cutoff value of 40 or 50% was used, the risk estimates stabilized at a fourfold increased risk (RR 3.9; 95% CI 2.8 to 5.1).
We performed additional sensitivity analyses to test more specific definitions of CKD, using eGFR Ͻ45 and Ͻ30 ml/min, respectively. In total, 252 (19%) patients had an eGFR Ͻ45 ml/min and 124 (9%) patients had eGFR Ͻ30 ml/min. For both definitions, temporary renal function decline remained an independent predictor of long-term CKD (eGFR Ͻ45: RR 2.2 [95% CI 1.7 to 2.8]; eGFR Ͻ30: RR 3.1 [95% CI 2.1 to 4.5]).
To confirm the validity of the results, we repeated all analyses using the RIFLE classification for AKI. Logistic regression analyses demonstrated that Risk (RR 3.6; 95% CI 2.6 to 4.8), Injury (RR 3.3; 95% CI 1.8 to 5.1), and Failure (RR 4.6; 95% CI 2.6 to 6.6) were independent predictors of CKD. Finally, to address that death is a competing end point of CKD, we studied the combined end point of death and CKD. Using the combined end point, temporary and persistent declines remained independent predictors of the primary end point incident CKD and death (temporary: RR 2.1 [95% CI 1.6 to 3.0]; persistent: RR 2.2 [95% CI 1.6 to 3.1]); however, the magnitude of the ORs decreased.
Discussion
To our knowledge, this study is the first to show that temporary perioperative renal function decline is an independent predictor for the development of incident CKD during longterm follow-up. During the perioperative period, Ͼ40% of the Adjustment for demographics (age, gender), cerebrovascular history, cardiovascular risk factors (polyvascular disease, smoking, hypertension, diabetes, hypercholesterolemia, heart failure, chronic obstructive pulmonary disease), baseline CKD-EPI eGFR, and BP-lowering drugs (diuretics, angiotensin-converting enzyme inhibitors, calcium antagonists, and angiotensin receptor blockers).
patients developed temporary or persistent renal function decline, which was invariably associated with the development of CKD independent of other important confounders that are known to be associated with kidney disease progression.
Ischemia-reperfusion injury as a result of hypotension or sepsis is one of the major causes of AKI (15) . Ischemia and/or reperfusion initiates changes in vascular endothelial cells, tubular epithelial cells, and leukocytes that result in the loss of immune system homeostasis in the kidney with a consequent inflammatory response (16) . Animal studies have demonstrated that AKI causes permanent damage to the microvasculature with subsequent abnormalities in kidney structure and function (17) . Basile et al. (18) demonstrated that recovery from ischemia-reperfusion injury in rats is not complete and that it compromises sodium hemostasis and predisposes to hypertension and secondary renal disease. In addition, this same group of investigators reported that in rats that were recovering from acute renal failure, genes with known inflammatory, remodeling, and vasoactive activities were identified, some of which may play a role in altering long-term renal function (19 -21) . In human studies, it has been demonstrated that after an episode of AKI, residual kidney injury promotes the release of inflammatory markers such as C-reactive protein, IL-6, and D-dimer (22) . In combination with fibrotic signaling pathways, these inflammatory pathways can lead to progressive structural kidney damage (6) . This silent, ongoing process predisposes to worsening hypertension, proteinuria, and more rapid decreases in renal function, all of which are widely known risk factors for kidney disease progression and establishment of CVD (5,7).
The incidence of AKI varies between 2 and 45%, depending on the study population and the definition used for AKI (2-4). Especially, patients who undergo surgical procedures and have a high risk for ischemia-reperfusion injury as a consequence of hemodynamic instabilities are at increased risk for AKI (2, 4) . The association between the development of AKI and increased rates of in-hospital mortality has been widely known for decades and has been reported in several studies (4, 23, 24) ; however, the association of AKI and long-term outcome, especially incident CKD, has been less studied. This could be a result of the seeming reversibility of the clinical episode as observed by improvements in Scr levels. Better understanding of the impact of AKI on long-term outcomes may identify a segment of patients who may need extended follow-up after discharge. A meta-analysis by Coca et al. (6) demonstrated that in hospitalized patients, AKI is common and is an independent predictor of long-term myocardial infarction and all-cause mortality (RRs 1.6 to 2.6 and 1.6 to 3.9, respectively); however, in this analysis, the RR for incident CKD after AKI was unattainable because of lack of follow-up studies with appropriate control subjects who did not have AKI. In this study, 11% of the patients with normal or improved renal function during the perioperative period developed CKD during long-term follow-up. These findings are in line with several (general) population studies in which the incidence of CKD ranged between 10 and 17% (7, 25, 26) . CKD was defined according the NKF/DOQI definition, using a cutoff value of eGFR Ͻ60 ml/min per 1.73 m 2 . Stevens et al. (27, 28) demonstrated that eGFR near 60 ml/min per 1.73 m 2 should be interpreted with caution; therefore, we performed additional sensitivity analyses using more specific definitions of CKD (eGFR Ͻ45 and Ͻ30 ml/min per 1.73 m 2 ), which demonstrated a change in the strength of the predictive value. Both temporary and persistent renal function decline remained independent predictors of long-term CKD, however. Importantly, because the number of patients with more advance CKD decreased significantly, the results for these cutoffs need to be interpreted with some caution.
In this study we are the first to describe the value of a small, temporary impairment in renal function as an independent predictor of long-term CKD. The prognostic importance of small, acute decrements in renal function has been studied in several surgical and intensive care unit populations. Coca et al. (8) summarized these results in a meta-analysis and demonstrated that patients with a 10 to 24% increase in Scr levels had a RR for death of 1.8 (95% CI 1.3 to 2.5). A graded relation between the increase in Scr levels and adverse outcome in a variety of clinical settings and patient types was observed. Welten et al. (10) demonstrated that although renal function may recover completely after aortic surgery, temporary decline of renal function was still associated with increased mortality during long-term follow-up. It has been noted by other investigators that the use of smaller changes in Scr levels to define AKI are more likely to be only a reflection of hemodynamic changes than real kidney injury (29) and that small or very temporary increases in Scr are simply markers for comorbid conditions. In this study, we used a cutoff value of 10% change in CKD-EPI eGFR compared with baseline preoperative CKD-EPI eGFR. To evaluate the predictive strength of this small, temporary change in CKD-EPI eGFR, we performed additional sensitivity analyses using a stepwise increased cutoff value of 20, 30, 40, and 50% change in CKD-EPI GFR compared with baseline. It is interesting that there seemed to be a dosagedependent relationship between the magnitude of exposure and the risk for outcome in patients with a temporary decline of renal function. In patients with a persistent decline of renal function after the perioperative period, the dosage-dependent relationship was observed up to a cutoff of 30%. Although the graded association was not completely observed for both groups, these findings strongly suggest that even small, temporary deteriorations in renal function are already an independent predictor for development of long-term CKD. Importantly, in additional sensitivity analyses using the RIFLE criteria for AKI, both temporary and persistent declines in renal function became even stronger predictors for development of long-term CKD; however, because the focus of this study was on small changes of renal function in relation to outcome, the 10% definition was used for the study outcomes.
This study supports the use of small changes in renal function in daily clinical practice, because both temporary and persistent declines in renal function were independent predictors of development of CKD. These small changes in Scr are a reflection of the onset of AKI; therefore, early management of AKI should be initiated. Despite the seeming reversible nature of clinical AKI, more attention should be given to perioperative impairment in renal function. Episodes of AKI confer increased risk for CKD and CVD; therefore, follow-up and risk factor should be monitored more closely. In addition, medical therapies that are known to prevent these outcomes could be applied earlier and more aggressively.
Potential limitations of this study merit consideration. This study has the disadvantage of a retrospective design. As a consequence, data on long-term Scr levels were not available for all patients in the source population but for 59% of the patients. To study the possibility of selection bias, we compared the source population and the study population regarding baseline characteristics, and no significant differences were observed. Furthermore, patients with established CKD before surgery were excluded from the study. As a consequence of the study design, we were not able to study the influence of AKI on kidney disease progression in patients with established CKD. During the follow-up period, Scr levels were not measured at prespecified time points. Multivariate analyses were adjusted for the time between surgery and the last Scr level recorded, and additional sensitivity analyses were performed; however, the presence of potential survival bias in patients with multiple Scr measurements during long-term follow-up has to be acknowledged.
There is a possibility of ascertainment bias because patients with increased risk for CKD were likely to have more frequent Scr measurements. In addition, informative censoring could not be completely ruled out regarding the influence of CKD and death on the occurrence of the end point; however, sensitivity analyses using a combined end point of CKD and death demonstrated that temporary and persistent renal function declines remained independent predictors of the primary end point.
There are several definitions for AKI; however, none of them includes small changes in renal function. In addition, we evaluated the presence of AKI only during the first 3 postoperative days and did not examine specific causes of AKI. Furthermore, Scr levels at day of hospital discharge were not available. In the literature, there is a growing consensus to use the RIFLE criteria, but these do not include small changes in Scr levels; therefore, in this study, we used the cutoff value of 10% in CKD-EPI eGFR on the basis of previous studies and a meta-analysis (8, 10) . It has to be noted that, independent of which prediction equation is used to estimate GFR, the changes in GFR in the acute setting are always difficult to interpret and a limitation of this study. Finally, although a minor dosage-dependent relationship between the magnitude of exposure (e.g., higher cutoff values) and the risk for outcome was observed, these data should be viewed as hypothesis-generating for future studies.
Conclusions
Temporary or persistent perioperative decline of renal function has a high incidence in the vascular surgery population. Temporary decline of renal function was an independent prognostic predictor for the development of CKD during long-term follow-up.
